2-Bromoethyl methyl ether → HCID 42633095, compound
Reaction equation
Cl.Cl.Cl.[C:4]1([N:10]2[CH2:15][CH2:14][N:13]([C:16]([O:18][CH2:19][CH2:20][N:21]3[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]3)=[O:17])[CH2:12][CH2:11]2)[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[CH3:27][O:28][CH2:29][CH2:30]Br.CCN(C(C)C)C(C)C>CN(C=O)C>[NH3:10].[C:4]1([N:10]2[CH2:15][CH2:14][N:13]([C:16]([O:18][CH2:19][CH2:20][N:21]3[CH2:26][CH2:25][N:24]([CH2:30][CH2:29][O:28][CH3:27])[CH2:23][CH2:22]3)=[O:17])[CH2:12][CH2:11]2)[CH:5]=[CH:6][CH:7]=[CH:8][CH:9]=1Participants
Reactant 3
Product 2
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 170 °C
Procedure
2-(piperazin-1-yl)ethyl 4-phenylpiperazine-1-carboxylate (None HCl salt of Example 30; 311 mg, 0.98 mmol) was dissolved in DMF (2 mL). 2-bromoethyl methyl ether (92 μl, 0.98 mmol) and DIPEA (0.3 mL, 1.72 mmol) were added and the reaction mixture was heated at 170° C. for 15 minutes in a Biotage Initiator microwave at high absorption. The reaction mixture was concentrated in vacuo, dissolved in 1 M aq Na2CO3 solution (25 mL) and extracted with DCM (3×25 mL), dried (MgSO4) and concentrated in vacuo. The residue was purified by normal phase column chromatography (eluting with DCM, followed by a 200:8:1 mixture of DCM:EtOH:NH3) to give 2-(4-(2-methoxyethyl)-piperazin-1-yl)ethyl 4-phenylpiperazine-1-carboxylate (163 mg, 44%) as a yellow oil.
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- dissolutiondissolved in 1 M aq Na2CO3 solution (25 mL)
- extractionextracted with DCM (3×25 mL)
- dry with materialdried (MgSO4)
- concentrationconcentrated in vacuo
- customThe residue was purified by normal phase column chromatography (
- washeluting with DCM
- additionfollowed by a 200:8:1 mixture of DCM
Sources & evidence
- ORD record
- ord-8e575756313a490f895e942dd0897966
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08093248B2
Reaction notes
Loading…